Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2015
16th World Conference on Lung Cancer
Access to all presentations that occur during the 16th World Conference on Lung Cancer in Denver, Colorado
Presentation Date(s):- September 6 - 9, 2015
- Total Presentations: 2499
To review abstracts of the presentations below, narrow down your search by using the Filter options below, and then select the session listing of your choice. Click the "+" for a presentation to expand & view the corresponding Abstract details.
-
+
JCHS - Joint IASLC - Chinese Society for Clinical Oncology - Chinese Alliance Against Lung Cancer Session
- Type: Joint Chinese/ English Session
- Track: Other
- Presentations: 14
- Moderators:C. Bai
- Coordinates: 9/06/2015, 07:30 - 10:30, Mile High Ballroom 1a-1f
-
+
JCHS.07 - First-Line Icotinib Versus Cisplatine/Pemetrexed plus Pemetrexed Maintenance in Advanced NSCLC Patients with EGFR Mutation
09:15 - 09:25 | Author(s): Y. Shi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P1.01 - Poster Session/ Treatment of Advanced Diseases – NSCLC
- Type: Poster
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 87
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.01-051 - Efficiency of Nab-Paclitaxel as a Late Phase Chemotherapy for NSCLC
09:30 - 09:30 | Author(s): M. Higuchi
- Abstract
Loading...
-
+
P1.02 - Poster Session/ Treatment of Localized Disease – NSCLC
- Type: Poster
- Track: Treatment of Localized Disease - NSCLC
- Presentations: 39
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.02-005 - Impact of Postoperative Complications on Cancer Recurrence following Lung Cancer Surgery
09:30 - 09:30 | Author(s): T. Nojiri
- Abstract
Loading... -
+
P1.02-010 - What Is the Difference between Lung Cancer and Infectious Lung Disease in Predicted Postoperative Pulmonary Function after Pneumonectomy?
09:30 - 09:30 | Author(s): T. Nakagawa
- Abstract
Loading...
-
+
P1.03 - Poster Session/ Treatment of Locoregional Disease – NSCLC
- Type: Poster
- Track: Treatment of Locoregional Disease – NSCLC
- Presentations: 31
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.03-003 - A Clinicopathological Study of Resected Small-Sized Non-Small Cell Lung Cancer 2 cm or Less in Diameter with N2 Lymph Node Metastasis
09:30 - 09:30 | Author(s): Y. Kato
- Abstract
Loading...
-
+
P1.04 - Poster Session/ Biology, Pathology, and Molecular Testing
- Type: Poster
- Track: Biology, Pathology, and Molecular Testing
- Presentations: 116
- Coordinates: 9/07/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P1.04-035 - Clinicopathologic and Biological Characteristics of Young Age Non-Small Cell Lung Cancer
09:30 - 09:30 | Author(s): T. Ohira
- Abstract
Loading... -
+
P1.04-109 - Antitumor Efficacy of Histone Deacetylase Inhibitor or in Combination with EGFR-TKI in Non-Small Cell Lung Cancer Cell Lines
09:30 - 09:30 | Author(s): X. Han
- Abstract
Loading...
-
+
ORAL 01 - Chemotherapy Developments for Lung Cancer
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 7
- Moderators:G. Blumenschein
- Coordinates: 9/07/2015, 10:45 - 12:15, 401-404
-
+
ORAL01.06 - S-1 and Cisplatin versus Docetaxel and Cisplatin in Patients with Untreated Advanced NSCLC: An Randomised, Multicenter, Phase 3 Trial
11:39 - 11:50 | Author(s): Y. Shi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
ORAL 03 - New Kinase Targets
- Type: Oral Session
- Track: Treatment of Advanced Diseases - NSCLC
- Presentations: 8
- Moderators:F. Blackhall
- Coordinates: 9/07/2015, 10:45 - 12:15, Mile High Ballroom 4a-4f
-
+
ORAL03.01 - Anlotinib as 3rd-Line Treatment for Refractory Advanced NSCLC: A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial
10:45 - 10:56 | Author(s): B. Han
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.02 - Poster Session/ Treatment of Localized Disease – NSCLC
- Type: Poster
- Track: Treatment of Localized Disease - NSCLC
- Presentations: 41
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.02-004 - Clinicopathological Features and Outcomes of AAH, AIS and MIA in Resected Lung Adenocarcinoma
09:30 - 09:30 | Author(s): H. Ishida
- Abstract
Loading...
-
+
P2.03 - Poster Session/ Treatment of Locoregional Disease – NSCLC
- Type: Poster
- Track: Treatment of Locoregional Disease – NSCLC
- Presentations: 38
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.03-035 - Impact of Lymph Node Involvement on Survival in Patients with Completely Resected Pulmonary Squamous Cell Carcinoma
09:30 - 09:30 | Author(s): Y. Kudo
- Abstract
Loading...
-
+
P2.05 - Poster Session/ Prevention and Tobacco Control
- Type: Poster
- Track: Prevention and Tobacco Control
- Presentations: 11
- Coordinates: 9/08/2015, 09:30 - 17:00, Exhibit Hall (Hall B+C)
-
+
P2.05-010 - The Chronic Respiratory Infection as a Background of the Lung Cancers
09:30 - 09:30 | Author(s): T. Yoshida
- Abstract
Loading...